Unlock.Healthcare: AI-Driven Personalized Medicine with Plant-Based Therapies
Imagine a healthcare experience that doesn’t begin with a prescription pad or a rushed doctor’s visit—but with you.
That’s the radical, yet intuitive, vision behind Unlock.Healthcare, an Israel-based digital health platform rewriting the rules of medicine through biomarker data, AI technology, and the therapeutic power of plants. In a system dominated by standardized treatment plans and impersonal metrics, Unlock is shifting the focus back to the patient—one individual at a time.
“We’re creating a future where healthcare adapts to the patient, not the other way around,” says Itay Segal, who co-founded the company with his brother Asaf Segal, Dr. Jean Claudr Scicluna , Chief Medical Officer and Asher Atias, the company’s CTO. The Segal brothers’ inspiration came from a personal crisis: Their father was gravely injured in a motorcycle accident and left in chronic pain. Prescribed heavy opioids, he initially followed doctors’ orders—but the side effects were terrible.
Fearing the spiral of dependency, the family began exploring alternatives. Working with physicians open to integrative therapies, they slowly introduced cannabinoid-based medicine into his regimen. The results were immediate and profound.
“Instead of watching him fall into dependency, we turned to cannabis,” Itay explains. “Now he’s on a hybrid model—using cannabinoids in tandem with low-dose opioids, carefully calibrated to his needs.”
That experience led to the founding of Unlock.Healthcare, designed to scale that same kind of integrative, personalized care. It begins with a comprehensive intake and biomarker analysis to assess symptoms, body chemistry, and health goals. From there, the platform builds an individualized plan that may include cannabinoid medicine, natural supplements, and lifestyle support.
But this isn’t just another wellness platform. Unlock’s proprietary digital caregiver—a mobile health companion—monitors patient response in real time, adjusts protocols, and keeps patients and providers closely connected. It’s like having a doctor, coach, and data scientist in your pocket.
“Your biology isn’t static, so your care shouldn’t be either,” says Itay. “That’s the whole point of personalization—your treatment evolves with you.”
Joining the Segal brothers is Jamie Pearson, a leading cannabis entrepreneur and Unlock board member. Her path to the company came through her own negative experience with conventional medicine.
“Someone close to me was overprescribed,” Pearson recalls. “That was the wake-up call. I realized how normalized and dangerous overmedication truly is.”
Stories like hers are all too common. Patients managing chronic conditions, mental health issues, or autoimmune disorders often find themselves stuck in cycles of ineffective or harmful pharmaceutical regimens. Unlock offers a different approach: evidence-based, plant-forward, and patient-centric.
“We’re not anti-pharma,” Pearson emphasizes. “We’re pro-patient. People deserve treatment that works for their lives, not against them.”
That philosophy runs through the company’s operations—from sustainable cannabinoid sourcing to partnerships with telemedicine clinics, pharmacies, and researchers. Unlock is currently active in Europe and Israel, with South America coming soon and broader plans to expand to North America and beyond.
“We’re building the future of healthcare in real time,” says Asaf. “Our platform helps people take control of their health journey with science-backed, holistic support.”
For many, the journey starts with a condition—chronic pain, anxiety, insomnia, skin issues—but what they discover goes further: agency. Unlock users often report not just symptom relief, but a renewed understanding of their bodies and how they heal. This is healthcare as transformation.
Through ongoing collaborations with universities, biotech companies, and patient advocacy groups, Unlock is also contributing to a global data ecosystem—one where patients play an active role in shaping the future of medicine.
“It’s not just about individual care,” Itay notes. “It’s about changing how we think about health entirely. We need to move from crisis response to proactive, adaptive support.”
Unlock’s digital caregiver uses real-time feedback and biomarker tracking to refine treatment plans as users’ needs evolve. The platform integrates with providers and manufacturers to create a seamless experience, aiming to reduce the friction and fragmentation that plague modern medicine.
Looking ahead, the company is scaling its model to reach populations underserved by traditional systems. Its commitment to ethics, sustainability, and user empowerment places it at the forefront of the personalized medicine movement.
Whether you’re managing medication side effects, optimizing your performance, or seeking natural solutions for pain and stress, Unlock offers a new entry point—starting with your story.
This is more than a tech platform—it’s a quiet revolution with real results. Welcome to the future of medicine!
—
To learn more, visit Unlock.Healthcare. Follow @UnlockHealthcare to stay up to date on their mission to make precision care global.
